http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111100066-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2030-027 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-07 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N30-02 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4465 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-02 |
filingDate | 2019-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2021-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2021-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-111100066-B |
titleOfInvention | Tirofiban hydrochloride intermediate and preparation method of Tirofiban hydrochloride |
abstract | The invention provides a tirofiban hydrochloride intermediate and a preparation method of tirofiban hydrochloride, wherein the tirofiban hydrochloride intermediate and the tirofiban hydrochloride prepared by the method have the isomer content of not higher than 0.5 percent, preferably not higher than 0.3 percent, and more preferably not higher than 0.1 percent; the prepared medicinal composition has various indexes meeting the medicinal requirements, has stable quality in the placing process, and can ensure the clinical curative effect and the medication safety. |
priorityDate | 2019-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 61.